APA

Fantini M., David J. M., Annunziata C. M., Morelli M. P., Arlen P. M. & Tsang K. Y. (20201120). The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway. : Cancer biotherapy & radiopharmaceuticals.

Chicago

Fantini Massimo, David Justin M, Annunziata Christina M, Morelli Maria Pia, Arlen Phillip M and Tsang Kwong Y. 20201120. The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway. : Cancer biotherapy & radiopharmaceuticals.

Harvard

Fantini M., David J. M., Annunziata C. M., Morelli M. P., Arlen P. M. and Tsang K. Y. (20201120). The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway. : Cancer biotherapy & radiopharmaceuticals.

MLA

Fantini Massimo, David Justin M, Annunziata Christina M, Morelli Maria Pia, Arlen Phillip M and Tsang Kwong Y. The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway. : Cancer biotherapy & radiopharmaceuticals. 20201120.